Literature DB >> 16443489

Clinical diagnosis and management of Alzheimer's disease.

Mustafa M Husain1, Robert K Garrett.   

Abstract

The diagnosis of dementia of the Alzheimer's type is defined by criteria from the Diagnostic and Statistical Manual of Mental Disorders, Fourth Edition and the National Institute of Neurologic, Communicative Disorders and Stroke-AD and Related Disorders Association. The latter divides diagnosis into definite, probable, and possible Alzheimer's disease (AD), with definitive diagnosis requiring pathologic confirmation. Both criteria require that other causes of dementia are excluded. A diagnosis of AD can be made with reasonably high accuracy using a combination of clinical criteria, neuropsychologic testing, and conventional CT and MR imaging. There is increasing emphasis on early recognition. Although current therapies produce a mild improvement in symptoms, there are several disease-modifying therapies on the horizon. This article reviews current standards in clinical diagnosis and management.

Entities:  

Mesh:

Year:  2005        PMID: 16443489     DOI: 10.1016/j.nic.2005.09.005

Source DB:  PubMed          Journal:  Neuroimaging Clin N Am        ISSN: 1052-5149            Impact factor:   2.264


  5 in total

1.  Characterizing regional correlation, laterality and symmetry of amyloid deposition in mild cognitive impairment and Alzheimer's disease with Pittsburgh Compound B.

Authors:  Cyrus A Raji; James T Becker; Nicholas D Tsopelas; Julie C Price; Chester A Mathis; Judith A Saxton; Brian J Lopresti; Jessica A Hoge; Scott K Ziolko; Steven T DeKosky; William E Klunk
Journal:  J Neurosci Methods       Date:  2008-05-16       Impact factor: 2.390

2.  Development of a Novel Urine Alzheimer-Associated Neuronal Thread Protein ELISA Kit and Its Potential Use in the Diagnosis of Alzheimer's Disease.

Authors:  Lina Ma; Rong Wang; Ying Han; Shuli Sheng; Jianan Zhu; Zhijuan Ji; Zhiwei Zhao; Ziqing Cao; Peichang Wang
Journal:  J Clin Lab Anal       Date:  2015-06-03       Impact factor: 2.352

Review 3.  Targeting β-amyloid plaques and oligomers: development of near-IR fluorescence imaging probes.

Authors:  Hongwu Liu; Jian Yang; Letian Wang; Yungen Xu; Siyuan Zhang; Jie Lv; Chongzhao Ran; Yuyan Li
Journal:  Future Med Chem       Date:  2017-01-27       Impact factor: 3.808

Review 4.  Toward systems neuroscience in mild cognitive impairment and Alzheimer's disease: a meta-analysis of 75 fMRI studies.

Authors:  Hui-Jie Li; Xiao-Hui Hou; Han-Hui Liu; Chun-Lin Yue; Yong He; Xi-Nian Zuo
Journal:  Hum Brain Mapp       Date:  2014-11-19       Impact factor: 5.038

5.  Present and prospective clinical therapeutic regimens for Alzheimer's disease.

Authors:  Mustafa M Husain; Kenneth Trevino; Haroon Siddique; Shawn M McClintock
Journal:  Neuropsychiatr Dis Treat       Date:  2008-08       Impact factor: 2.570

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.